Kearny Venture Associates Iii, Llc
Venture capitalLate Stage
Investment thesis
Kearny Venture Partners invests exclusively in emerging healthcare products, believing the opportunity for entrepreneurs to create innovative medical solutions is greater than ever. The firm sees persistent unmet needs in healthcare as large market opportunities for safe and effective products. As the molecular basis of disease becomes better understood, new avenues for intervention emerge and novel therapies can displace incumbent products. The firm aims to partner with and help transform exceptional companies advancing medicine.
Source: firm website, verified Aug 3, 2026.
Frequently asked questions
- What stage does Kearny Venture Associates Iii, Llc invest at?
- Kearny Venture Associates Iii, Llc invests at the Late Stage stage.
- What sectors does Kearny Venture Associates Iii, Llc focus on?
- Kearny Venture Associates Iii, Llc focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.